newsfilter
← Latest News
PR Newswire·

Inhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

SAN DIEGO, May 8, 2023 /PRNewswire/ -- Inhibrx, Inc. (NASDAQ:INBX), or Inhibrx, or the Company, a biopharmaceutical company with four clinical programs in development and a strong emerging pipeline, today reported